Saint-Petersburg, Russia

Aleksei Leonidovich Mindich

This inventor holds 1 USPTO granted patent and 2 published patent applications. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Aleksei Leonidovich Mindich. Retrieved from https://idiyas.com/inventor/aleksei-leonidovich-mindich

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 13.0

ph-index = 1


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Aleksei Leonidovich Mindich: Innovator in CDK8/19 Inhibitors

Aleksei Leonidovich Mindich is a notable inventor based in St. Petersburg, Russia. He has made significant contributions to the field of pharmaceuticals, particularly through his work on CDK8/19 inhibitors. His innovative approach has led to the development of novel compounds that hold promise for treating various diseases and disorders.

Latest Patents

Aleksei Mindich holds a patent for CDK8/19 inhibitors. This invention relates to novel compounds of formula I, which exhibit properties as CDK8/19 inhibitors. The patent also includes a pharmaceutical composition comprising these compounds and outlines their use as a medicine for treating diseases and disorders.

Career Highlights

Throughout his career, Aleksei Mindich has focused on advancing medical science through innovative research. His work on CDK8/19 inhibitors showcases his commitment to developing effective treatments for complex health issues. His contributions have the potential to impact the pharmaceutical industry significantly.

Collaborations

Aleksei has collaborated with talented individuals such as Anna Jur'evna Chestnova and Mariia Andreevna Kasatkina. These partnerships have enriched his research and contributed to the successful development of his patented compounds.

Conclusion

Aleksei Leonidovich Mindich is a distinguished inventor whose work on CDK8/19 inhibitors represents a significant advancement in pharmaceutical innovation. His dedication to research and collaboration highlights the importance of teamwork in achieving groundbreaking results.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…